Home » Authors » Anette Breindl

Articles by Anette Breindl

Targeting One Channel Through Another For Specific Anesthesia

Oct. 4, 2007

By Anette Breindl

Targeting One Channel Through Another For Specific Anesthesia

Oct. 4, 2007

By Anette Breindl

Study Shows Delivery Method Key To Whether RNAi Is Toxic

Oct. 1, 2007

By Anette Breindl

Study Shows Delivery Method Key To Whether RNAi Is Toxic

Oct. 1, 2007

By Anette Breindl

New Targets Good, Combined Markets Better To Attack NTDs

Sep. 26, 2007

By Anette Breindl

New Targets Good, Combined Markets Better To Attack NTDs

Sep. 26, 2007

By Anette Breindl

Sirtuins And Mitochondria, P53 And Insulin Are Longevity Teams

Sep. 24, 2007

By Anette Breindl

Sirtuins And Mitochondria, P53 And Insulin Are Longevity Teams

Sep. 24, 2007

By Anette Breindl

Marker, Culture Advances Give Plentiful Adult Stem Cell Source

Sep. 20, 2007

By Anette Breindl

Marker, Culture Advances Give Plentiful Adult Stem Cell Source

Sep. 20, 2007

By Anette Breindl

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 24, 2025
Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal
BioWorld
The J.P. Morgan (JPM) Healthcare Conference in San Francisco kicked off with a resounding bang as Johnson & Johnson (J&J) disclosed plans to acquire...
Proteomics study explores how protein changes influence disease
BioWorld Science
Fourteen global pharma companies are getting together to conduct the largest proteomics study to date, analyzing 600,000 blood samples held in the UK Biobank to...
Abbvie and Simcere enter a $1B T-cell engager deal
BioWorld Asia
Abbvie Inc. and Simcere Zaiming Pharmaceutical Co. Ltd. are part of the volley of large deals accompanying the opening of the 43rd annual J.P. Morgan Healthcare...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.